Skip to content

Clinical trials

Phase 4 Atherosclerosis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Phase 4 Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20121
20131
20152
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Anzhen Hospital1
China National Center for Cardiovascular Diseases1
Chinese PLA General Hospital1
Junjie Yang1
Li Bo1
Peking Union Medical College Hospital1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shandong Provincial Hospital1
The Affiliated Hospital of Xuzhou Medical University1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis10
Diabetes Mellitus, Type 22
Stroke2
COVID-191
Carotid Artery Diseases1
Carotid Stenosis1
Coronary Artery Disease1
Coronary Disease1
Dyslipidemias1
Endocrine System Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.